Cargando…
Gene Therapy of the Hemoglobinopathies
Sickle cell disease and the ß-thalassemias are caused by mutations of the ß-globin gene and represent the most frequent single gene disorders worldwide. Even in European countries with a previous low frequency of these conditions the prevalence has substantially increased following large scale migra...
Autores principales: | Kunz, Joachim B., Kulozik, Andreas E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7489710/ https://www.ncbi.nlm.nih.gov/pubmed/32984772 http://dx.doi.org/10.1097/HS9.0000000000000479 |
Ejemplares similares
-
Gene Therapy for Hemoglobinopathies
por: Cavazzana, Marina, et al.
Publicado: (2018) -
Gene Therapy in Thalassemia and Hemoglobinopathies
por: Breda, Laura, et al.
Publicado: (2009) -
Gene Therapy for β-Hemoglobinopathies: From Discovery to Clinical Trials
por: Segura, Eva Eugenie Rose, et al.
Publicado: (2023) -
Curing Hemoglobinopathies: Challenges and Advances of Conventional and New Gene Therapy Approaches
por: Motta, Irene, et al.
Publicado: (2019) -
Infections in Thalassemia and Hemoglobinopathies: Focus on Therapy-Related Complications
por: Ricerca, Bianca Maria, et al.
Publicado: (2009)